UAE News Online
Main » Entries archive
SUNNYVALE, Calif. - Sunday, May 5th 2013 [ME NewsWire]

(BUSINESS WIRE)-- DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.

The DVS Sciences® CyTOF 2 system leverages the same mass cytometry technology that has been the foundation to the success and world-wide adoption of the CyTOF Mass Cytometer. The technology enables comprehensive functional and phenotypic characterization of complex systems at the single cell level in diverse disciplines including immunology, cancer research, stem cell biology and drug profiling. On a newly designed chassis, the CyTOF 2 system delivers enhanced performance and improved user experience, providing the most powerful cell analysis platform on the market. The CyTOF 2 platform uniquely has t ... Read more »
Views: 84 | Added by: africa-live | Date: 05.05.2013

La société organisera une conférence téléphonique le lundi 6 mai

DUBLIN - Dimanche 5 Mai 2013 [ME NewsWire]

(BUSINESS WIRE)--La société Covidien (NYSE : COV), l'un des principaux fournisseurs de matériel médical à l'échelle mondiale, a annoncé aujourd'hui ses grandes orientations pour 2013 et rendu publics des états financiers historiques révisés pour tenir compte des activités qu'elle prévoit abandonner en raison de la cession de ses activités pharmaceutiques. Ces états financiers révisés couvrent les exercices 2010 à 2012, ainsi que le premier trimestre de l'exercice 2013. Ceux relatifs au deuxième trimestre seront rendus publics fin mai.

«Depuis l'annonce, en décembre 2011, de la cession de nos activités pharmaceutiques, nous avons fait des progrès considérables»

La société Covidien ... Read more »
Views: 68 | Added by: uaeonlinenews | Date: 05.05.2013

First Trump Course in Asia to be ‘Among the Finest in the World’


Dubai, United Arab Emirates- - Sunday, May 5th 2013 [ME NewsWire]

DAMAC Properties, the largest private developer of luxury real estate in the Middle East, has announced plans to develop an 18-hole PGA Championship Golf Course, to be named Trump International Golf Club, Dubai.

The 7,205-yard, par 71 course will be located just ten minutes from Sheikh Zayed Road and sits at the heart of the 28 million square foot ‘Akoya by DAMAC’ master plan development - the launch of which was announced last week. Construction is already underway and the course will be ready for play next year.

Trump International Golf Club, Dubai will include a 30,000 square foot state-of-the-art club house and a luxurious Trump Spa & wellness centre, which will be managed to the highest standards by the Trump Organization.

"By collaborating with Donald Trump, we are bringing the most elite name in golf and in ... Read more »
Views: 65 | Added by: uaeonlinenews | Date: 05.05.2013

Company will hold conference call on Monday, May 6

DUBLIN - Sunday, May 5th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced revised 2013 guidance and released historical financial statements adjusted for the upcoming expected discontinued operations, reflecting the planned spin-off of its Pharmaceuticals business. These adjusted financial statements cover fiscal years 2010 to 2012 and the first quarter of fiscal 2013. Adjusted financial statements for the second quarter of fiscal 2013 will be available by the end of May.

Covidien announced fiscal 2013 guidance to reflect the planned spin-off of its Pharmaceuticals business, a transaction that is expected to occur following the close of trading on June 28, 2013. The Company now estimates that net sales in fiscal 2013 will be up 4% to 5%, including foreign exchange at current rates. Sales are expected to be up 4% to 6% versus 2012 in the Me ... Read more »
Views: 83 | Added by: uaeonlinenews | Date: 05.05.2013

SUNNYVALE dans l'État de Californie - Dimanche 5 Mai 2013 [ME NewsWire]

(BUSINESS WIRE)--DVS Sciences, Inc., un innovateur non coté de nouveaux analyseurs de cellules uniques à paramètres multiples et de réactifs pour la recherche biologique, a annoncé aujourd'hui l'introduction du nouveau cytomètre de masse CyTOF 2 et des nouveaux ensembles de panneaux MaxPar conçus spécifiquement pour l'analyse simultanée de cellules uniques à paramètres élevés.

Le système CyTOF 2 de DVS Sciences® tire profit de la même technologie de cytométrie de masse que celle qui a été à l'origine de la réussite et de l'adoption internationale du cytomètre de masse CyTOF. La technologie permet une caractérisation fonctionnelle et phénotypique complète de systèmes complexes au niveau de cellules uniques dans diverses disciplines, notamment l'immunologie, la recherche contre le cancer, la biologie de ... Read more »
Views: 77 | Added by: africa-live | Date: 05.05.2013

MONTRÉAL - Samedi 4 Mai 2013 [ME NewsWire]

(BUSINESS WIRE)--Silanis Technology a annoncé aujourd'hui que Forrester Research Inc. l'a reconnue comme l'un des leaders des signatures numériques dans son rapport intitulé « The Forrester Wave™: E-Signatures, Q2 2013 ». Selon ce rapport : « L'offre de solutions de Silanis sur place et hébergées en fait le fournisseur le plus solide ».

Silanis se trouvait parmi les sociétés d'élite que Forrester a invitées pour participer à l'élaboration de ce rapport sur les signatures numériques, qui compare 10 fournisseurs de signatures numériques selon trois catégories et dix-huit critères. Forrester a attribué d'excellentes notes à Silanis pour les catégories relatives à l'offre, la stratégie et la présence sur le marché, et les scores maximums (5/5) pour les critères suivants :

    Captu ... Read more »
Views: 80 | Added by: uaeonlinenews | Date: 05.04.2013

Dubaï, Émirats Arabes Unis - Samedi 4 Mai 2013 [ME NewsWire]

Les chefs d’entreprises ont appelé l’Afrique à libérer tout son potentiel et à collaborer avec Dubaï pour tirer profit du pouvoir de ses secteurs clés à l’occasion du Forum Mondial des Affaires en Afrique 2013, organisé en présence et sous le haut patronage de Son Altesse Cheikh Mohammed bin Rashid AL Maktoum vice-président des Émirats Arabes Unis, premier ministre et gouverneur de Dubaï.

4500 délégués se sont réunis durant l’évènement qui a duré deux jours, pour discuter les opportunités d’affaires dans les secteurs agroalimentaire, commercial, logistiques et les services financiers.

Rt. Amama Mbabazi, premier ministre de la république de l’Ouganda, S.E. Sultan Al Mansouri, ministre de l’économie des Émirats Arabes Unis, S.E. Reem Al Hashimy, ministre d’état des Émir ... Read more »
Views: 79 | Added by: uaeonlinenews | Date: 05.04.2013

Dubai, United Arab Emirates - Thursday, May 2nd 2013 [ME NewsWire]

Business leaders urged Africa to realise its full potential and work with Dubai to harness the power of its key sectors, at the Africa Global Business Forum 2013, held under the attendance and patronage of H.H. Sheikh Mohammed bin Rashid Al Maktoum, UAE Vice President and Prime Minister and Ruler of Dubai.

Over the two-days, more than 4,500 attendees came together to discussed exponential business opportunities in agribusiness, trade, logistics and financial services.

The first day was attended by Rt. Hon. Amama Mbabazi, Prime Minister of the Republic of Uganda, H.E. Sultan Al Mansouri, UAE Minister of Economy, H.E. Reem Al Hashimy, UAE Minister of State, H.E. Sindiso Ngwenya, Secretary General, COMESA, and Hon. Danny Faure, Vice President of the Republic of Seychelles, among other dignitaries and business leaders.

In his keynote address, Rt. Hon. Mbabazi stressed that Africa could learn from ... Read more »
Views: 85 | Added by: uaeonlinenews | Date: 05.04.2013

SAINT PREX, Switzerland - Thursday, May 2nd 2013 [ME NewsWire]

(BUSINESS WIRE)-- Ferring Pharmaceuticals today announced it has initiated enrolment of patients in two phase III clinical trials of elobixibat for the treatment of chronic idiopathic constipation (CIC), a common gastrointestinal disorder affecting approximately 14% of the general population1. The two studies, Echo 1 and Echo 2, will be conducted at close to 200 sites worldwide and will enrol nearly 1700 patients. The studies aim to demonstrate the efficacy and safety of repeated daily doses of elobixibat against placebo over a period of up to 26 weeks.

Elobixibat is a first-in-class compound with a novel physiological mechanism of action. It acts locally in the gut with minimal systemic exposure to enhance the amount of luminal bile acids in the colon by a partial inhibition of the Ileal Bile Acid Transporter (IBAT). This increases colonic fluid secretion and motility. Phase II clinical trials with elobixibat ... Read more »
Views: 122 | Added by: uaeonlinenews | Date: 05.04.2013 | Comments (2)

MONTREAL - Thursday, May 2nd 2013 [ME NewsWire]

(BUSINESS WIRE)-- Silanis Technology today announced that Forrester Research Inc. has recognized Silanis as a Leader in e-signatures in the firm’s report The Forrester Wave™: E-Signatures, Q2 2013. The report states, "Silanis is the strongest vendor with both an on-premise and cloud offering.”

Silanis was among the select companies that Forrester invited to participate in the e-signatures report, which compared 10 electronic signature vendors across three categories and 18 criteria. Forrester cited Silanis with high scores in its current offering, strategy and market presence categories, with top scores (5/5) in criteria including:

    E-signature capture
    Sender configuration and customization
    Compliance with industry/country regulations and technical standards
    Authentication
    Electronic evidence
    ... Read more »
Views: 96 | Added by: uaeonlinenews | Date: 05.02.2013

« 1 2 ... 1736 1737 1738 1739 1740 ... 1860 1861 »